Therefore, it seems that allantoin could be involved in SREBP1c and PPARα expressions and thereby change their downstream enzyme expression, promote TG and cholesterol metabolism, and lead to NASH improvement. This evidence concerns the gene PPARA and metabolic dysfunction-associated steatohepatitis.